N-(2,3-DIHYDRO-2-OXO-1H-BENZIMIDAZOL-5-YL)-3-HYDROXY-4-((2-METHOXY-5-((PHENYLAMINO)CARBONYL)PHENYL)AZO)NAPHTHALENE-2-CARBOXAMIDE
UNII PPD399X5ES
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxy-4-((2-methoxy-5-((phenylamino)carbonyl)phenyl)azo)naphthalene-2-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PPD399X5ES.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 12225-06-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C32H24N6O5 LOGJDHWBDGLMNO-HEFFKOSUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(2,3-dihydro-2-oxo-1h-benzimidazol-5-yl)-3-hydroxy-4-((2-methoxy-5-((phenylamino)carbonyl)phenyl)azo)naphthalene-2-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.